Seth Lederman, Tonix Pharmaceuticals CEO

Tonix rais­es $144M in a di­rect of­fer­ing fol­low­ing pos­i­tive PhI­II da­ta for its fi­bromyal­gia drug

Tonix Phar­ma­ceu­ti­cals said it’s rais­ing $144 mil­lion in a di­rect of­fer­ing that in­cludes $30 mil­lion up­front on the same day that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.